Bioventus BVS
NASDAQ BVS
$13.13 -0.32 (-2.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bioventus (BVS) Asset Writedowns and Impairment (2022 - 2024)

Updated

Bioventus (BVS) posted Asset Writedowns and Impairment of $2.46 million for Q4 2024, up 20.9% from the prior quarter.

Analysis

Bioventus (BVS) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends

For FY2024, Bioventus' Asset Writedowns and Impairment came in at $36.36 million, down 53.8% from FY2023.

  • Annual Asset Writedowns and Impairment shows a three-year compound annual growth rate of 72.8% (FY2021 to FY2024).
  • In prior years, Bioventus' Asset Writedowns and Impairment was $78.62 million in FY2023 (-41.8%), $134.98 million in FY2022 and $7.04 million in FY2021.
  • Quarterly Asset Writedowns and Impairment has run from a low of $2.03 million in Q3 2024 to a high of $124.7 million in Q3 2022 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bioventus 1.10 Bn 993.30 Mn 105.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.46 Mn
Sep 28, 2024 2.03 Mn
Jun 29, 2024 31.87 Mn
Apr 1, 2023 78.62 Mn
Dec 31, 2022 10.29 Mn
Oct 1, 2022 124.70 Mn
API Access

Bioventus Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BVS&period=max&api_key=YOUR_API_KEY